Skip to main content
HLB Pep Co., Ltd. logo

HLB Pep Co., Ltd. — Investor Relations & Filings

Ticker · 196300 ISIN · KR7196300008 KO Manufacturing
Filings indexed 277 across all filing types
Latest filing 2019-04-22 Major Shareholding Noti…
Country KR South Korea
Listing KO 196300

About HLB Pep Co., Ltd.

http://hlbpep.co.kr/eng/main/

HLB Pep Co., Ltd. is a biopharmaceutical company specializing in the research, development, and production of peptide-based biomaterials and new drugs. The company's core activities include the manufacturing of peptide Active Pharmaceutical Ingredients (APIs) in a GMP-certified facility. It offers a range of products and services, including generic peptides, custom peptide synthesis for research and development, and a catalog of approximately 1,000 research peptides such as hormones and neuropeptides. HLB Pep focuses on discovering new drug candidates and aims to commercialize them through technology transfer.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is the standard Korean regulatory filing for reporting significant changes in share ownership (often referred to as the 5% rule filing). It details the reporter (Kim Jae-il), special related parties, their shareholding ratios, and a chronological log of stock transactions. This fits the definition of a 'Major Shareholding Notification'.
2019-04-22 Korean
기타경영사항(특허권취득)(자율공시)(고세렐린의 제조 방법)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from a Korean company (Anygen) regarding the acquisition of a patent ('기타 경영사항(특허권 취득)'). It details the patent name, content, and commercial application. Since it does not fit into specific categories like financial reports, dividends, or management changes, it falls under the general regulatory announcement category.
2019-04-17 Korean
기타경영사항(특허권취득)(자율공시)(부세렐린의 제조 방법)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by the company Anygen. It details the patent name, content, and utilization plan. Since this is a specific regulatory announcement regarding corporate operations that does not fit into financial reporting, dividend, or management change categories, it is classified as a general regulatory filing.
2019-04-17 Korean
사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Anygen Co., Ltd. for the fiscal year 2018 (Jan 1, 2018 to Dec 31, 2018). It contains detailed company information, history, capital changes, shareholding structure, and business descriptions. In the South Korean regulatory context, the 'Business Report' (사업보고서) is the equivalent of the US 10-K annual report, as it is the comprehensive annual filing submitted to the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). FY 2018
2019-03-28 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend decisions, and director appointments. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2019-03-26 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory filing from a Korean company (Anygen) announcing a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). This is a standard material event disclosure required by the Korea Exchange (KRX) for significant contracts. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2019-03-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.